Overgaard M, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337(14):949–55.

Article  CAS  PubMed  Google Scholar 

Overgaard M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353(9165):1641–8.

Article  CAS  PubMed  Google Scholar 

Ragaz J, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337(14):956–62.

Article  CAS  PubMed  Google Scholar 

Ebctcg, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–35.

Article  Google Scholar 

Clarke M, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.

Article  CAS  PubMed  Google Scholar 

Whelan TJ, Olivotto IA, Levine MN. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(19):1878–9.

PubMed  Google Scholar 

Poortmans PM, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317–27.

Article  CAS  PubMed  Google Scholar 

Goyal A, Dodwell D. POSNOC: A randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. Clin Oncol (R Coll Radiol). 2015;27(12):692–5.

Article  CAS  PubMed  Google Scholar 

Recht A, et al. Postmastectomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. J Clin Oncol. 2016;34(36):4431–42.

Article  PubMed  Google Scholar 

Ragaz J, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97(2):116–26.

Article  PubMed  Google Scholar 

Fisher B, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567–75.

Article  PubMed  Google Scholar 

Krag DN, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33.

Article  PubMed  PubMed Central  Google Scholar 

Veronesi U, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595–600.

Article  PubMed  Google Scholar 

Savolt A, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43(4):672–9.

Article  CAS  PubMed  Google Scholar 

Donker M, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303–10.

Article  PubMed  PubMed Central  Google Scholar 

Giuliano AE, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–26.

Article  PubMed  PubMed Central  Google Scholar 

Galimberti V, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385–93.

Article  PubMed  Google Scholar 

Kodali A, Gadi VK. Preoperative systemic therapy for breast cancer. Surg Clin North Am. 2023;103(1):201–17.

Article  PubMed  Google Scholar 

Thorsen LB, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34(4):314–20.

Article  PubMed  Google Scholar 

Kyndi M, et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26(9):1419–26.

Article  CAS  PubMed  Google Scholar 

Tseng YD, et al. Biological subtype predicts risk of locoregional recurrence after mastectomy and impact of postmastectomy radiation in a large national database. Int J Radiat Oncol Biol Phys. 2015;93(3):622–30.

Article  PubMed  Google Scholar 

Mamounas EP, et al. 21-Gene recurrence score and locoregional recurrence in node-positive/ER-positive breast cancer treated with chemo-endocrine therapy. J Natl Cancer Inst. 2017:109(4).

Kalinsky K, et al. 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Group CCT Regional radiotherapy in biomarker low-risk node positive and T3N0 breast cancer (TAILOR RT). Available from: https://clinicaltrials.gov/ct2/show/NCT03488693. Accessed 1 May 2023.

Velikova G, et al. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. Lancet Oncol. 2018;19(11):1516–29.

Article  PubMed  Google Scholar 

Giuliano AE, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borm KJ, et al. Irradiation of regional lymph node areas in breast cancer - dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design. Radiother Oncol. 2020;142:195–201.

Article  CAS  PubMed  Google Scholar 

Jagsi R, et al. Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol. 2014;32(32):3600–6.

Article  PubMed  PubMed Central  Google Scholar 

MacDonald Sci, F.M., et al. Breast contouring RADCOMP consortium. 2016.

Google Scholar 

Kim YB, et al. Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial. JAMA Oncol. 2022;8(1):96–105. This randomized study of 735 patients showed that internal mammary node irradiation (IMNI) did not improve disease-free survival in the study cohort as a whole, the subgroup of patients with medial/central node-positive tumors benefitted from IMNI.

Article  PubMed  Google Scholar 

Jethwa KR, et al. Delineation of internal mammary nodal target volumes in breast cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(4):762–9.

Article  PubMed  Google Scholar 

van den Bogaard VA, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35(11):1171–8.

Article  PubMed  PubMed Central  Google Scholar 

Darby SC, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.

Article  CAS  PubMed  Google Scholar 

Taylor C, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9.

Article  PubMed  PubMed Central  Google Scholar 

Shaitelman SF, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162(2):201–15.

Article  CAS  PubMed  Google Scholar 

Kataria T, et al. Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents. Breast. 2013;22(6):1125–9.

Article  PubMed  Google Scholar 

Offersen BV, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114(1):3–10.

Article  PubMed  Google Scholar 

White Ta, J. A. D., et al. Breast cancer atlas for radiation therapy planning: Consensus definitions. 2009.

Google Scholar 

Bazan JG, Khan AJ. Target volume delineation and patterns of recurrence in the modern era. Semin Radiat Oncol. 2022;32(3):254–69. This review article is an essential summary of the differences among the various breast contouring atlases, patterns of recurrence, and implications for modern treatment planning acorss a variety of techniques.

Article  PubMed  Google Scholar 

Smith BD, et al. Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8(3):145–52.

Article  PubMed  Google Scholar 

Whelan TJ, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513–20.

Article